Oak Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
504
+59
+13% +$60.3K 0.29% 44
2026
Q1
$409K Hold
445
0.22% 45
2025
Q4
$478K Buy
445
+10
+2% +$9.56K 0.27% 41
2025
Q3
$332K Hold
435
0.19% 46
2025
Q2
$339K Hold
435
0.22% 44
2025
Q1
$359K Hold
435
0.27% 41
2024
Q4
$336K Buy
+435
New +$360K 0.26% 45

Other funds holding LLY

Oak Wealth Advisors's LLY Position: Q2 2026 in Review

Oak Wealth Advisors increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $60.3K and bringing the position to 504 shares worth $605K. The position accounts for 0.29% of the portfolio, ranked #44.

Oak Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,583 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oak Wealth Advisors held 504 shares of Eli Lilly worth $605K as of Q2 2026.
  • Oak Wealth Advisors bought 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
  • Eli Lilly made up 0.29% of Oak Wealth Advisors's portfolio in Q2 2026, its #44 holding.
  • Oak Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,583 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oak Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.